Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1074601 | 0.79 | TSHR (0.34) | HPGD | |
| SCHEMBL933331 | 0.74 | TSHR (0.34) | HPGD | |
| SCHEMBL9519745 | 0.69 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL8432137 | 0.68 | — | — | |
| SCHEMBL9519740 | 0.66 | PTGS2 (0.39) | HPGD | |
| Cyazofamid SCHEMBL16180421 | 0.65 | PTGS2 (0.38) | — | |
| SCHEMBL9323957 | 0.64 | — | — | |
| SCHEMBL1074589 | 0.63 | PTGS1 (0.41) | HPGD | |
| SCHEMBL9519533 | 0.62 | HTT (0.31) | — | |
| SCHEMBL5718754 | 0.62 | SMN1; SMN2 (0.38) | HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6713500-B2 | IMIDAZOLE DERIVATIVES; FOR CONTROLLING COCCIDIOSIS | ISHIHARA SANGYO KAISHA LTD. (JP) | 2004-03-30 | — | — | US | claimed |
| US-6713500-B2 | IMIDAZOLE DERIVATIVES; FOR CONTROLLING COCCIDIOSIS | ISHIHARA SANGYO KAISHA LTD. (JP) | 2004-03-30 | — | — | US | disclosed |
| US-20030100586-A1 | Agent for controlling animal diseases caused by parasites | ISHIHARA SANGYO KAISHA LTD. (JP) | 2003-05-29 | — | — | US | disclosed |
| EP-1211245-A1 | AGENTS FOR CONTROLLING ANIMAL DISEASES CAUSED BY PARASITES | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2002-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030100586-A1 | Agent for controlling animal diseases caused by parasites | CLIC1, CLIC4, H1-4 | HPGD 4313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.